Skip to Content

Bumetanide Injection

Last Updated: March 28, 2018
Status: Current

Bumetanide Injection

Products Affected - Description
    • Bumetanide injection, Pfizer, 0.25 mg/mL, 10 mL vial, 10 count, NDC 00409-1412-10
    • Bumetanide injection, Pfizer, 0.25 mg/mL, 4 mL vial, 10 count, NDC 00409-1412-04
    • Bumetanide injection, West-Ward, 0.25 mg/mL, 10 mL vial, 10 count, NDC 00641-6007-10
    • Bumetanide injection, West-Ward, 0.25 mg/mL, 4 mL vial, 10 count, NDC 00641-6008-10
Reason for the Shortage
    • Pfizer has bumetanide injection on shortage due to manufacturing delays.
    • West-Ward did not provide a reason for the shortage.

Estimated Resupply Dates

    • Pfizer has bumetanide 0.25 mg/mL 4 mL and 10 mL vials on back order and the company estimates a release date of June 2019.
    • West-Ward has bumetanide 0.25 mg/mL 4 mL and 10 mL vials on a weekly allocation.

Updated

Updated March 28, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created May 4, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide